Cargando…
Metformin and long non-coding RNAs in breast cancer
Breast cancer (BC) is the second most common cancer and cause of death in women. In recent years many studies investigated the association of long non-coding RNAs (lncRNAs), as novel genetic factors, on BC risk, survival, clinical and pathological features. Recent studies also investigated the roles...
Autores principales: | Gholami, Morteza, Klashami, Zeynab Nickhah, Ebrahimi, Pirooz, Mahboobipour, Amir Ali, Farid, Amir Salehi, Vahidi, Aida, Zoughi, Marziyeh, Asadi, Mojgan, Amoli, Mahsa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969691/ https://www.ncbi.nlm.nih.gov/pubmed/36849958 http://dx.doi.org/10.1186/s12967-023-03909-x |
Ejemplares similares
-
The Effect of Metformin on Expression of Long Non-coding RNA H19 in Endometrial Cancer
por: Aminimoghaddam, Soheila, et al.
Publicado: (2021) -
An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity
por: Gholami, Morteza, et al.
Publicado: (2020) -
Association of microRNA gene polymorphisms with Type 2 diabetes mellitus: A systematic review and meta-analysis
por: Gholami, Morteza, et al.
Publicado: (2020) -
Vascular Endothelial Growth Factor Genetic Variant Is Associated with in-Stent Restenosis after Percutaneous Coronary Intervention
por: Asgarbeik, Saeedeh, et al.
Publicado: (2022) -
Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity
por: Gholami, Morteza, et al.
Publicado: (2022)